Amphastar Pharmaceuticals, Inc. (AMPH) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $23.13M2013: $17.64M2014: $20.50M2015: $16.00M2016: $21.38M2017: $35.10M2018: $46.81M2019: $41.55M2020: $33.85M2021: $27.46M2022: $24.03M2023: $38.17M2024: $41.04M2025: $34.88M$34.88M
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$34.88M-15.0%
2024$41.04M+7.5%
2023$38.17M+58.8%
2022$24.03M-12.5%
2021$27.46M-18.9%
2020$33.85M-18.5%
2019$41.55M-11.2%
2018$46.81M+33.4%
2017$35.10M+64.2%
2016$21.38M+33.7%
2015$16.00M-22.0%
2014$20.50M+16.2%
2013$17.64M-23.7%
2012$23.13M